RxDoctor Payments DataLook up a doctor →

Stephen Gold, DO

Family Medicine · Lancaster, PANPI 1366402208

Payments from drug & device makers

$77,512in general payments, 2019–2025

Across 2,023 payments — averaging $38.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$44K
  • AstraZeneca$6K
  • Novo Nordisk$4K
  • Pfizer$3K
  • Lilly USA, LLC$2K
  • GSK$1K
  • plus $17K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)310$44,139
AstraZeneca(2 entities)192$5,539
Novo Nordisk191$4,159
Pfizer208$2,617
Lilly USA, LLC109$1,758
GSK78$1,376
Boehringer Ingelheim61$1,068
Bayer43$954
Axsome Therapeutics, Inc.24$910
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC59$875
Merck62$859
Teva Pharmaceuticals USA, Inc.40$784
Phathom Pharmaceuticals, Inc.23$750
Otsuka America Pharmaceutical, Inc.34$730
Sanofi-aventis U.S. LLC46$698
Novartis26$604
Amgen(2 entities)31$567
Astellas Pharma US Inc20$471
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)20$458
Ironwood Pharmaceuticals, Inc29$443
Amarin Pharma, Inc.37$440
Biohaven Pharmaceutical Holding Company Ltd.8$386
Lundbeck LLC21$385
Abbott21$371
Corcept Therapeutics18$330
Verona Pharma, Inc.19$317
Biohaven Pharmaceuticals, Inc.16$292
Exact Sciences13$286
E.r. Squibb & Sons, L.L.C.7$264
Esperion Therapeutics, Inc.13$254
Biodelivery Sciences International, Inc.15$245
Neurocrine Biosciences, Inc.12$240
Antares Pharma, Inc.13$216
Inari Medical, Inc.1$209
Sunovion Pharmaceuticals Inc.15$201
Jazz Pharmaceuticals Inc.9$195
Takeda Pharmaceuticals U.S.A., Inc.18$181
OPKO Pharmaceuticals, LLC5$179
Johnson & Johnson10$178
Impel Pharmaceuticals Inc.2$174
Supernus Pharmaceuticals, Inc.24$164
Kowa Pharmaceuticals America, Inc.11$162
Currax Pharmaceuticals LLC9$151
Mannkind Corporation8$136
Bausch Health US, LLC7$122
Adlon Therapeutics L.p.6$111
Comsort, Inc1$100
Vivus LLC1$97
Nabriva Therapeutics, PLC6$90
Nestle Healthcare Nutrition Inc.6$89
Eisai Inc.5$83
Collegium Pharmaceutical, Inc.5$82
Sumitomo Pharma America, Inc.2$70
Vanda Pharmaceuticals Inc.3$60
Boston Scientific4$59
Avion Pharmaceuticals2$58
Dexcom, Inc.3$55
Idorsia Pharmaceuticals US Inc3$52
Rhythm Pharmaceuticals, Inc.2$51
Medtronic(2 entities)3$50

How this compares

$77,512 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$120,322
Medicare patients
311
Services billed
2,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Lancaster

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →